Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials.

Silvestro, Marcello; Orologio, Ilaria; Siciliano, Mattia; Trojsi, Francesca; Tessitore, Alessandro; Tedeschi, Gioacchino; Russo, Antonio

Silvestro, Marcello; Orologio, Ilaria; Siciliano, Mattia; Trojsi, Francesca; Tessitore, Alessandro; Tedeschi, Gioacchino; Russo, Antonio.

Afiliación

Silvestro M; Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Orologio I; Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Siciliano M; Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Trojsi F; Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Tessitore A; Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Tedeschi G; Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Russo A; Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Expert Opin Emerg Drugs ; 28(2): 79-96, 2023 12.

Article en En | MEDLINE | ID: mdl-37185047

Asunto(s)

Péptido Relacionado con Gen de Calcitonina; Trastornos Migrañosos; Humanos; Péptido Relacionado con Gen de Calcitonina/metabolismo; Antagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitonina/farmacología; Antagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitonina/uso terapéutico; Anticuerpos Monoclonales/efectos adversos; Preparaciones Farmacéuticas; Calidad de Vida; Trastornos Migrañosos/tratamiento farmacológico; Trastornos Migrañosos/prevención & control

Palabras clave

Atogepant; CGRP; eptinezumab erenumab; fremanezumab; galcanezumab; gepant; monoclonal antibody; rimegepant

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Péptido Relacionado con Gen de Calcitonina / Trastornos Migrañosos Límite: Humans Idioma: En Revista: Expert Opin Emerg Drugs Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google